Thumbnail

COVID-19 complicated by high Venous Thromboembolism (VTE) and bleed risk in critically ill patients.

  • Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
 Learn more Contact us

VTE Prevention

Barnsley Hospital NHS Foundation Trust

Reducing VTE risk in obstetrics patients

View Partner

Wound therapy

Welsh Wound Innovation Centre
& The University of Cardiff,
School of Medicine

Breaking the cycle of chronic wounds

View Partner

Post-operative oedema prevention

Spire Edinburgh Hospital, Murrayfield

Preventing post-operative oedema formation
in foot & ankle surgery

View Partner

Wound therapy

Countess of Chester Hospital
NHS Foundation Trust

Accelerating closure of hard-to-heal complex wounds

View Partner

VTE Prevention

Royal Stoke University Hospital, UHNM NHS Trust

Reducing VTE risk in acute stroke patients

View Partner

Pre-operative oedema reduction

The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust

Accelerating readiness for theatre
in ankle fracture patients

View Partner

OnPulse Technology

The revolutionary neuromuscular electrostimulation technology developed by Firstkind

Find out more

geko™ product

Hospital Applications Device

Find out more

geko™ product

Wound Therapy Applications Device

Find out more

Partner with us

What can the geko™ do for my patients?

Find out more

News

Navigating the financial hurdles in a MedTech start-up

Read more All news

Blog

Neuromuscular electrostimulation (NMES) device in the healing of leg ulcers

Read more All blogs

Social Media

Follow our social media channels to read our latest updates

Find out more
Social Media